|
0
|
|
Systemic light chain and transthyretin amyloidosis-treatment advancements and future directions.
(linkinghub.elsevier.com)
|
Bianchi G
…
Merlini G
The Lancet
2026-07-08
|
#amyloid
#transthyretin
#immunotherapy
#therapeutics
#protein misfolding
|
|
0
|
|
Toward precision microbiome therapeutics: From black box to blueprint.
(linkinghub.elsevier.com)
|
Gelsinger DR
…
Wang HH
Cell Host & Microbe
2026-07-08
|
#microbiome
#metagenomics
#therapeutics
#gut
#genome editing
|
|
0
|
|
Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases
2026-07-08
|
#long covid
#clinical trial
#fatigue
#therapeutics
|
|
0
|
|
Gut microbiota alters drug metabolism and therapeutic outcomes.
(linkinghub.elsevier.com)
|
Guo F
…
Lei X
Cell Host & Microbe
2026-07-08
|
#microbiome
#metabolism
#therapeutics
#pharmacology
#personalized medicine
|
|
0
|
|
Advances and challenges in microbiome transplantation.
(linkinghub.elsevier.com)
|
Sen P
…
Elinav E
Cell Host & Microbe
2026-07-08
|
#microbiome
#transplantation
#infection
#therapeutics
#dysbiosis
|
|
0
|
|
Co-targeting TWIST1 and JUNB suppresses CCL2-induced cell motility and hybrid EMT in ESCC models.
(nature.com)
|
Ling Z
…
Tao X
Communications Biology
2026-07-08
|
#metastasis
#emt
#esophageal cancer
#therapeutics
#signaling
|
|
0
|
|
Evolution of antifungal drug resistance: Challenges and mitigations.
(linkinghub.elsevier.com)
|
Lee Y
…
Cowen LE
Cell Host & Microbe
2026-07-08
|
#amr
#antifungal
#pathogen
#therapeutics
|
|
0
|
|
ALOX15 orchestrates mitochondrial antiviral immunity and serves as a host target for anti-influenza therapy.
(nature.com)
|
Weng JY
…
He RR
Nature Immunology
2026-07-08
|
#influenza
#immunity
#signaling
#mitochondria
#therapeutics
|